Strategic Industrial Sourcing: Powering GCC Pharma Localization.

Validated, SFDA & EDE Ready APIs and Excipients from Elite German Manufacturers.

Request a Sourcing Audit Review Technical Capabilities

Beyond Procurement:

A Technical Bridge for Sovereign Manufacturing

SFDA & MoHAP Readiness

Skip the 6–12 month trial and error. We do not just find suppliers; we pre-audit German Site Master Files (SMF) to guarantee immediate compliance with KSA Vision 2030 and UAE Operation 300bn localization mandates

The Technical Translator

We seamlessly align European dossiers into the precise Common Technical Document (CTD) format required by Gulf authorities, ensuring zero registration delays.

Climatic Zone IVb Alignment

We eliminate stability testing failures before importation begins. We ensure your German source provides raw materials and APIs backed by robust stability data explicitly validated for the extreme hot and humid zones (30°C / 75% RH) of the Middle East.

How We Work:
Industrial Sourcing Process

Source Qualification & Audit

EU-GMP Pre-Auditing & SMF Validation

Regulatory Dossier Alignment

eCTD Module 3 & Zone IVb Stability Matching

Compliance & Sanctions Shielding

Dual-Use Screening & EUC Verification

Direct Contracting & GDP Logistics Execution

Transparent § 52c AMG Mediation & Freight Coordination

Our Brokerage Advantages

GMP & SMF Pre-Validation (The Entry Key)

Pre-verified German sources. Validated science

Pre-audits of European Site Master Files (SMFs) for target market readiness.
Validation powered by our founder’s 10 years of direct experience in German Biopharma Quality Assurance (QA) and GMP.
Full management of consular legalization processes for GCC registration.

Driven by our deep internal QA experience, Levant Gate Pharma UG performs rigorous pre-mediation audits of elite German chemical manufacturers. We ensure their SMF and legalized GMP certificates are strictly recognized by your target Ministry of Health, transforming high-risk procurement into a seamless regulatory handover.

Asset-Light Brokerage

Direct B2B contracting. Zero hidden markups.

Operating strictly as a specialized broker.
Levant Gate Pharma UG (haftungsbeschränkt) takes no legal title to APIs, providing a “Clean Interface”.
Eliminates opaque middleman markups, ensuring optimal factory-direct pricing.

Traditional pharmaceutical wholesalers assume high-liability risks and hide margins during cross-border trade. Levante Gate Pharma UG is a Service and Compliance Partner, not a wholesaler. By facilitating direct commercial invoicing between the German manufacturer and the Middle Eastern industrial buyer, we guarantee pricing transparency and legal integrity.

Frequently Asked Questions on Industrial Sourcing

We do not perform direct product registrations. Instead, we pre-audit European Drug Master Files (DMF), Site Master Files (SMF), and Certificates of Suitability (CEP) from German manufacturers. We align technical documentation (CTD Module 3) with localized e-portal frameworks (SFDA in KSA, EDE in the UAE) and verify stability data for Climatic Zone IVb (30°C / 75% RH) before contracts are signed.

No. Operating strictly under Section 52c of the German Medicines Act (§ 52c AMG), LGP acts as a specialized technical mediator and regulatory interface. Regional buyers contract directly with EU-GMP certified German producers at true ex-works pricing. We coordinate export handling and GDP-compliant freight forwarders without taking physical ownership or applying middleman markups.

Every industrial transaction passes through our mandatory 4-Step Safety Protocol. We perform real-time OFAC and EU CFSP sanctions screening, execute dual-use chemical pre-clearance under EU Regulation 2021/821, and secure verified End-User Certificates (EUC) to guarantee BAFA export compliance and prevent customs delays.

We supply regional pharmaceutical factories with validated, SFDA- and EDE-ready APIs, high-purity excipients, and starting materials. Beyond raw material sourcing, we manage consular legalization in Germany and QP vendor pre-qualification audits to ensure regional plants meet European partner-readiness standards.

We focus on high-volume standard generics, essential APIs, excipients, and CE-marked medical devices. To eliminate conflicts of interest, we enforce a voluntary Therapeutic Negative List excluding patented innovative oncology (TKIs), SGLT2 inhibitors, oral anticoagulants, and complex LAMA/LABA/ICS respiratory formulations.

Secure Your Technical Consultation

Use the form below to outline your product portfolio (Standard Generics, Biosimilars, or Med-Tech hardware), and our lead consultant will contact your regulatory team within 24 business hours.